Table 2. Multivariable analysis of the incidence of positive urine dipstick albumin.

	HR	95% CI
Intention-to-treat analysis
Aspirin use	1.12	0.95	to	1.32
Age ≥65 years	1.23	1.04	to	1.46
Male sex	0.95	0.79	to	1.15
Serum creatinine	2.59	1.71	to	3.93
HbA1c ≥7.2%	1.38	1.16	to	1.63
Systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg	1.78	1.48	to	2.13
ACE inhibitor or ARB use at baseline	1.11	0.91	to	1.35
ACE inhibitor / ARB use at the time of the follow-up survey in 2009	0.98	0.81	to	1.18
On-treatment analysis
Aspirin use	1.08	0.92	to	1.27
Age ≥65 years	1.24	1.04	to	1.46
Male sex	0.95	0.79	to	1.15
Serum creatinine	2.61	1.72	to	3.96
HbA1c ≥7.2%	1.38	1.16	to	1.63
Systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg	1.80	1.50	to	2.15
ACE inhibitor or ARB use at baseline	1.10	0.91	to	1.33
ACE inhibitor / ARB use at the time of the follow-up survey in 2009	0.99	0.82	to	1.19

BP indicates blood pressure; ACE, angiotensin-converting enzyme; and ARB, angiotensin II type 1 receptor blocker.